← Eichor
Condition: Psychosis Acute Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Psychosis Acute

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acu
Phase 2 · 9 location(s) · VistaGen Therapeutics, Inc. · NCT06809179
Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NA · 8 location(s) · Stephanie Mehl · NCT07645443
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · 13 location(s) · LB Pharmaceuticals Inc. · NCT07363577
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Phase 4 · 1 location(s) · Northwell Health · NCT07483294
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.